Prin HEOR Specialist- Health Technology Assessments; HTA

We anticipate the application window for this opening will close on - 30 Jan 2026

At Medtronic you can begin a life‑long career of exploration and innovation, while helping champion healthcare access and equity for all. You’ll lead with purpose, breaking down barriers to innovation in a more connected, compassionate world.

The Principal Health Economics & Outcomes Research Specialist for Canada and Latin America will work closely with region‑specific Health Economics and Outcomes researchers to develop and implement strategies to optimize Market Access for the innovative diabetes devices such as insulin pumps, continuous glucose monitors, and Smart

MDI. The successful candidate will collaborate with region specific HEPR experts to develop HTA dossiers, and provide support on the design, execution, and dissemination of HEOR studies to meet the business needs. In this role, you will advise and collaborate with cross‑functional stakeholders including reimbursement, healthcare policy, marketing, payer marketing, medical affairs, and other functions.

This position is an exciting opportunity to work with Medtronic's Diabetes business. Medtronic has announced its intention to separate the Diabetes division to promote future growth and innovation within the business and reallocate investments and resources across Medtronic, subject to applicable information and consultation requirements. This separation provides our team with a bold opportunity to unleash our potential, enabling us to operate with greater speed and agility.

As a separate entity, we anticipate leveraging increased investments to drive meaningful innovation and enhance our impact on patient care.

Responsibilities may include providing input on clinical trial design and Real‑World Evidence (RWE) generation and communication.

• Works closely with the other functions within the Market Access team to support the development of evidence that will improve the understanding of the treatment of diabetes and will demonstrate the value of Medtronic’s extensive diabetes device profile. The data generated should inform strategic internal decisions as well.
• Develops HTA submission documents to meet requirements for optimal reimbursement, coverage, and utilization. Collaborates closely with regional Health Economics, Policy and Reimbursement (HEPR) teams to identify Canadian or Latin American specific evidence needs and synergies.
• Supports the design and implementation of observational and economic research studies or economic models including cost‑effectiveness, cost‑utility and budget impact models. These materials should provide value, perspective and evidence for clinical and/or pre‑clinical product portfolio decisions, marketing, regulatory agency submissions (HTA), and product reimbursement strategies.
• Conduct both systematic and targeted literature searches that will be foundational to the development of value dossiers suitable for HTA submissions in Canada and Latin America.
• Compares and evaluates the value of Medtronic’s products and therapies versus other products in the market basket with respect to the clinical, economic, and outcomes data from clinical trials and Real‑World Evidence (RWE) studies including epidemiology studies, registries, observational studies, payer pilots, cost‑effectiveness modeling, surveys, and meta‑analyses.
• Collaborates with the Clinical Development team to ensure that an integrated evidence plan including RWE is available to support country approval and reimbursement.
• Maintains a comprehensive knowledge of the evidence needed to inform government agencies in Canada and Latin America to secure reimbursement.
• Prepares observational and economic research study results for dissemination via abstracts, presentations, and/or peer‑reviewed publications.

Bachelor's degree and 7+ years of relevant experience in the healthcare industry

Or

Master’s degree and 5+ years of relevant experience in the healthcare industry

• Degree in Pharm
  
  D, Master’s degree, or PhD in epidemiology, health economics, biostatistics, public health
• An understanding of the HTA systems in Canada and Latin…